MYC and Miyoshi myopathy: Activation of MNK1 via phosphorylation has also been implicated in cap-independent c-Myc translation to facilitate survival during treatment with Rapamycin (and also with common MM chemotherapeutics expected to inhibit cap-dependent translation, such as bortezomib) (77, 88).